Tracing cancer back to birth uncovers promising biomarkers for prevention, targeted treatment of childhood leukemia

byMurdoch Children's Research InstituteDiscovery, validation and functional analysis of VTRNA2-1 methylation in association with pediatric pre-B ALL development. Credit:Molecular Cance

Updated on: November 11,2024

Tracing cancer back to birth uncovers promising biomarkers for prevention, targeted treatment of childhood leukemia

byMurdoch Children's Research InstituteDiscovery, validation and functional analysis of VTRNA2-1 methylation in association with pediatric pre-B ALL development. Credit:Molecular Cance

Updated on:November 11,2024

Shot could remove side effects from late-stage head and neck cancer therapy

by Kayla Wiles,Purdue UniversityCredit: CC0 Public DomainFor advanced stages of head and neck cancer, one of the best treatments is so aggressive that it could bring tooth decay, speech loss, co

Updated on: April 07,2024

Shot could remove side effects from late-stage head and neck cancer therapy

by Kayla Wiles,Purdue UniversityCredit: CC0 Public DomainFor advanced stages of head and neck cancer, one of the best treatments is so aggressive that it could bring tooth decay, speech loss, co

Updated on:April 07,2024

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Updated on: August 28,2024

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Updated on:August 28,2024

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes

Updated on: September 10,2024

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes

Updated on:September 10,2024

New model identifies women at high risk for endometrial cancer

byBrigham and Women's HospitalInclusion and exclusion of study participants from NHS II. Credit:JNCI: Journal of the National Cancer Institute(2023). DOI: 10.1093/jnci/djad014End

Updated on: January 15,2024

New model identifies women at high risk for endometrial cancer

byBrigham and Women's HospitalInclusion and exclusion of study participants from NHS II. Credit:JNCI: Journal of the National Cancer Institute(2023). DOI: 10.1093/jnci/djad014End

Updated on:January 15,2024

New book explores the history of the phony cancer drug Krebiozen

by Sharita Forrest,University of Illinois at Urbana-ChampaignCredit: 3 Fields BooksIn March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—he

Updated on: October 21,2024

New book explores the history of the phony cancer drug Krebiozen

by Sharita Forrest,University of Illinois at Urbana-ChampaignCredit: 3 Fields BooksIn March 1951, Andrew Ivy—at the time, one of the most renowned scientists and medical ethicists in the U.S.—he

Updated on:October 21,2024

Glass filters developed to separate tumor cells from blood may increase efficiency of blood tests for cancer

by Nagoya UniversityThe experimental setup to capture CTCs and CAFs. (a) Schematic of the experimental setup to capture CTCs and CAFs. (b) Photograph of the experimental setup around the glass fi

Updated on: January 30,2024

Glass filters developed to separate tumor cells from blood may increase efficiency of blood tests for cancer

by Nagoya UniversityThe experimental setup to capture CTCs and CAFs. (a) Schematic of the experimental setup to capture CTCs and CAFs. (b) Photograph of the experimental setup around the glass fi

Updated on:January 30,2024

Researchers uncover novel aspect of tumor evolution and potential targets for therapy

by Ludwig Institute for Cancer ResearchGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2022.12.003A Ludwig Cancer Research study has discovered that the immune s

Updated on: January 30,2024

Researchers uncover novel aspect of tumor evolution and potential targets for therapy

by Ludwig Institute for Cancer ResearchGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2022.12.003A Ludwig Cancer Research study has discovered that the immune s

Updated on:January 30,2024

Neutrophil PAD4: How does it function in cancer beyond promoting NETosis?

by Impact Journals LLCMechanisms involved in regulation of tumor progression by neutrophil PAD4. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28369A new editorial paper titled "N

Updated on: April 09,2024

Neutrophil PAD4: How does it function in cancer beyond promoting NETosis?

by Impact Journals LLCMechanisms involved in regulation of tumor progression by neutrophil PAD4. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28369A new editorial paper titled "N

Updated on:April 09,2024

Neoadjuvant nivolumab shows long-term benefit in patients with non–small cell lung cancer

byAmerican Association for Cancer ResearchA–D, Kaplan–Meier curves depicting the recurrence-free survival (A) and overall survival (B) for patients who underwent definitive resection after recei

Updated on: January 13,2024

Neoadjuvant nivolumab shows long-term benefit in patients with non–small cell lung cancer

byAmerican Association for Cancer ResearchA–D, Kaplan–Meier curves depicting the recurrence-free survival (A) and overall survival (B) for patients who underwent definitive resection after recei

Updated on:January 13,2024

Programming white blood cells to fight pancreatic cancer

by University of California - San DiegoPeter Yingxiao Wang, Ph.D. Credit: UC San Diego Jacobs School of EngineeringPancreatic cancer is the third most lethal cancer in the United States. Patients

Updated on: March 09,2024

Programming white blood cells to fight pancreatic cancer

by University of California - San DiegoPeter Yingxiao Wang, Ph.D. Credit: UC San Diego Jacobs School of EngineeringPancreatic cancer is the third most lethal cancer in the United States. Patients

Updated on:March 09,2024

Cytometry chip supports new revolution in cancer care for a truly personalized treatment plan

by IMECImec's cell sorter concept uses integrated star-shaped microheaters to push the target cells into a side channel. Credit: IMECImec teamed up with the KU Leuven laboratory of tumor immu

Updated on: March 05,2024

Cytometry chip supports new revolution in cancer care for a truly personalized treatment plan

by IMECImec's cell sorter concept uses integrated star-shaped microheaters to push the target cells into a side channel. Credit: IMECImec teamed up with the KU Leuven laboratory of tumor immu

Updated on:March 05,2024